Sign in

CIK 0001826457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
  1. 4 Planned sale President & CEO sold 5,466 shares at an average $19.44 ($106,253)
  2. 4 Planned sale Chief Scientific Officer sold 6,000 shares at $19.87 ($119,220)
  3. 4 Planned sale Chief Operating Officer sold 2,175 shares at $20.00 ($43,500)
  4. 4 Planned sale Chief Operating Officer sold 2,176 shares at $19.00 ($41,344)
  5. 4 Open-market sale Director sold 10,000 shares at $18.01 ($180,100)
  6. 4 Planned sale President & CEO sold 5,467 shares at $18.92 ($103,447)
  7. 4 Open-market sale President & CEO sold 8,000 shares at $17.64 ($141,125)
  8. 4 Open-market sale Chief Business & Legal Officer sold 5,845 shares at $17.69 ($103,413)
  9. 4 Grant or award Principal Accounting Officer acquired 4,300 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Principal Accounting Officer sold 139 shares at $17.96 ($2,496)
  12. 4 Planned sale President & CEO sold 5,466 shares at $17.92 ($97,974)
  13. 4 Open-market sale Principal Accounting Officer sold 25,700 shares at an average $18.09 ($464,886)
  14. 4 Open-market sale Chief Medical Officer sold 9,189 shares at $19.50 ($179,161)
  15. 4 Planned sale President & CEO sold 5,466 shares at an average $23.49 ($128,373)
  16. 4 Open-market sale Chief Business & Legal Officer sold 3,155 shares at $15.17 ($47,861)
  17. 4 Open-market sale Chief Operating Officer sold 2,629 shares at $15.17 ($39,882)
  18. 4 Open-market sale Principal Accounting Officer sold 1,039 shares at $15.17 ($15,762)
  19. 4 Open-market sale President & CEO sold 10,135 shares at $15.17 ($153,748)
  20. 4 Open-market sale Chief Medical Officer sold 3,155 shares at $15.17 ($47,861)

Page 2 of 9 · 171 filings